Last 77,700 KRW
Change Today +800.00 / 1.04%
Volume 9.4K
000070 On Other Exchanges
Korea SE
Korea SE
As of 2:03 AM 08/1/14 All times are local (Market data is delayed by at least 15 minutes).

samyang holdings corp (000070) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/16/13 - 91,900
52 Week Low
01/27/14 - 65,500
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SAMYANG HOLDINGS CORP (000070)

Related News

No related news articles were found.

samyang holdings corp (000070) Related Businessweek News

No Related Businessweek News Found

samyang holdings corp (000070) Details

Samyang Holdings Corporation, through its subsidiaries, is engaged in the chemicals, food, medicine, and other businesses in South Korea. The company’s Chemical business produces and sells chemical products that include high-value-added materials, terephthalic acid, polycarbonate resin, and bisphenol-A. Its Foodstuff business produces and sells brownie mixes, ice cream mixes, flour and premixes, fat and oil products, glucose, starch syrup, fructose, general and modified starch, sorbitol, maltitol, oligosaccharides, and other products; markets weight adjustment foodstuff under the BD Lab brand; and operates a salad and grill restaurant chain under the Seven Springs name, and a bakery café under the Mix & Bake name. The company’s Pharmaceutical business offers anti-cancer drugs, such as Genexol PM and Nanoxel PM; NicoStop, a smoking cessation patch; and Trisorb and Monosorb that are biodegradable sutures. Its Independent businesses include manufacturing of paper making machines; operation of pure-water manufacturing and wastewater treatment facilities; and provision of IT services to various companies in the public, finance, and manufacturing sectors. The company also exports its products to other countries. Samyang Holdings Corporation was founded in 1924 and is based in Seoul, South Korea.

Founded in 1924

samyang holdings corp (000070) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

samyang holdings corp (000070) Key Developments

Samyang Holdings Corporation, Annual General Meeting, Mar 21, 2014

Samyang Holdings Corporation, Annual General Meeting, Mar 21, 2014., at 10:30 Korea Standard Time. Location: first floor auditorium Jongno-gu. Agenda: To consider the group financial statements (including the statement of retained earnings) and approval of the consolidated financial statements; to consider the election of Directors; and to approve the director remuneration.

Sorrento Therapeutics Acquires the Exclusive Rights to Cynviloq to Expand into Australia, Canada and Mexico

Sorrento Therapeutics Inc. announced that it has acquired the exclusive rights to Cynviloq in Australia, Canada and Mexico from Samyang Biopharmaceuticals, a South Korean corporation. Sorrento has the exclusive rights to Samyang's Cynviloq (marketed as Genexol-PM in South Korea and other countries) in the US and the 27 countries of the EU. According to the company, Cynviloq (IG-001; a paclitaxel-loaded micellar diblock copolymer) is a next-generation branded paclitaxel formulation for the potential treatment of metastatic breast cancer, non-small cell lung cancer, pancreatic cancer and other solid tumors.

Samyang Reports Earnings Results for the Year Ended December 31, 2012

Samyang reported earnings results for the year ended December 31, 2012. For the year, the company reported profit after tax of KRW 26,129.0 million or KRW 4,763.0 earnings per share against profit after tax of KRW 103,291.1 million of prior year. EBIT was KRW 36,692.0 million. Return on equity and return on assets were 6.4% and 3.2% against 14.0% and 11.3% of prior year.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
000070:KS 77,700.00 KRW +800.00

000070 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 000070.
View Industry Companies

Industry Analysis


Industry Average

Valuation 000070 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.3x
Price/Book 0.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAMYANG HOLDINGS CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at